/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

G

Giovanni Randon

European Neuroendocrine Tumor Society(DE)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

199

Papers

2.6K

Citations

28

h-index

57

i10-index

Giovanni Randon is an academic researcher from European Neuroendocrine Tumor Society. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Cancer Genomics and Diagnostics & Genetic factors in colorectal cancer. The author has an h-index of 28, co-authored 170 publications.

ORCID: 0000-0003-0244-445X

Research Topics

Colorectal Cancer Treatments and Studies Cancer Genomics and Diagnostics Genetic factors in colorectal cancer Gastric Cancer Management and Outcomes Cancer Immunotherapy and Biomarkers

Papers by this author

works

Prognostic impact of ATM mutations in patients with metastatic colorectal cancer

2019 · Scientific Reports · 61 citations

https://doi.org/10.1038/s41598-019-39525-3

Giovanni Randon Giovanni Fucà Daniele Rossini Alessandra Raimondi

Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONO

2024 · Annals of Oncology · 60 citations

https://doi.org/10.1016/j.annonc.2024.11.016

A. Raimondi Sara Lonardi Sabina Murgioni Giovanni Gerardo Cardellino

Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy in patients with advanced HER2-negative gastric or gastro-oesophageal junction cancer (ARMANI): a randomised, open-label, multicentre, phase 3 trial

2024 · The Lancet Oncology · 21 citations

https://doi.org/10.1016/s1470-2045(24)00580-1

Giovanni Randon Sara Lonardi Matteo Fassan Federica Palermo

Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor–Positive Advanced Breast Cancer (EVERMET)

2021 · Clinical Cancer Research · 10 citations

https://doi.org/10.1158/1078-0432.ccr-20-4928

Claudio Vernieri Federico Nichetti Luca Lalli Luca Moscetti

EPSILoN score: Validation cohort of a prognostic score in advanced non-small cell lung cancer (aNSCLC) patients treated with immunotherapy

2019 · Annals of Oncology · 2 citations

https://doi.org/10.1093/annonc/mdz063.058

Arsela Prelaj Giuseppe Lo Russo Diego Signorelli Roberto Ferrara

Primary tumor sidedness and negative hyperselection to modulate anti-EGFR-based maintenance strategies in patients with RAS wild-type metastatic colorectal cancer: individual patient data pooled analysis of two randomized clinical trials

2025 · British Journal of Cancer · 1 citations

https://doi.org/10.1038/s41416-025-03164-5

Alexej Ballhausen Federica Morano Arndt Stahler Sara Lonardi

Research topics

topics

Colorectal Cancer Treatments and Studies

Cancer Genomics and Diagnostics

Genetic factors in colorectal cancer

Gastric Cancer Management and Outcomes

Cancer Immunotherapy and Biomarkers

Chat about Author

Papers

Chat

Click to start Chat